Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Earnings Momentum Penalize Citigroup (C) Rating

Citigroup Inc (NYSE:C) is ranked as a Hold using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking C has had from Portfolio Grader for the last month.

Flagging Earnings Momentum Make Wells Fargo & Co (WFC) a Sell

As one of the 757 companies in the GICS Financials sector Wells Fargo & Co (NYSE:WFC) is a constituent of the 340 company Banks GICS industry group within this sector. WFC has a market value of $276.9 billion which is in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 315 among the 340 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 691 among the 757 companies in the sector, and number 4,088 in the nearly 5,000 company Portfolio Grader universe.

Bank of America (BAC) Quant Score Hamper Rating

Bank of America Corp (NYSE:BAC) is one of the 757 companies in the GICS Financials sector, and a component of the 340 company Banks GICS industry group within this sector. BAC's market value is $293.9 billion which places it in the top decile in its industry group. The current Portfolio Grader ranking for BAC puts it 181 among the 340 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 430 among the 757 companies in the sector, and number 2,903 in the nearly 5,000 company Portfolio Grader universe.

Weak Industry Group Rank Drops JPMorgan Chase & Co (JPM) to Hold

The current recommendation of Hold for JPMorgan Chase & Co (NYSE:JPM) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The shares have been downgraded from a Buy to a Hold in the last week.

Berkshire Hathaway Energy (BRK.B) Earnings Visibility Penalize Rating

Berkshire Hathaway Energy Co (NYSE:BRK.B) is a constituent of the 16 company Diversified Financial Services GICS industry group, which is a segment of the 757 company GICS Financials sector. BRK.B's market value is $480.0 billion which falls in the top 10% of its industry group. The current Portfolio Grader ranking for BRK.B puts it 13 among the 16 companies in this industry group, a position that is well below-average; in the third quartile of the sector with a ranking of 439 among the 757 companies in the sector, and number 2,928 in the nearly 5,000 company Portfolio Grader universe.

Sales Growth Hamper Banco Santander Brasil (BSBR) Rating

Banco Santander Brasil SA (NYSE:BSBR) ranks in the top 10% of its industry group, Banks, and in the top 10% of its sector group, Financials, with a market value of $34,403.0 billion. From an investment attractiveness prospective, BSBR is ranked in the top half of the sector with a ranking of 296 among the 757 companies in the sector; Portfolio Grader's current ranking for BSBR puts it 125 among the 340 companies in this industry group, putting it in the second quartile and number 1,951 in the 5000 company Portfolio Grader company universe.

JD.Com Inc Stock Isn’t the Unstoppable Force You Think It Is

Although JD stock has been a top-performer among Chinese stocks, its underlying bullish argument isn’t without serious flaws.

This Is Where You Buy AutoZone, Inc. Stock

AutoZone is a great company with a volatile stock, but it's worth keeping an eye one for value in AZO stock after earnings.

Ascena Retail Group Inc (ASNA) Posts In-Line Earnings

Ascena Retail Group (ASNA) posted its quarterly earnings results after hours late Monday, which its profit meeting Wall Street's expectations.

Vertex Pharmaceuticals’ (VRTX) Strong Quant Score Make it a Buy

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a member of the 350 company Biotechnology GICS industry group, which is a segment of the 782 company GICS Health Care sector. The market value of VRTX is $35.6 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader score places it 32 among the 350 companies in this industry group, positioning it among the leaders; in the top quartile of the sector with a ranking of 102 among the 782 companies in the sector, and number 591 in the nearly 5,000 company Portfolio Grader universe.

MLP & Strategic Equity Fund (MTP) a Sell on Flagging Sales Growth

MLP & Strategic Equity Fund (NASDAQ:MTP) ranks in the top 10% of its industry group, Biotechnology, and in the top 10% of its sector group, Health Care, with a market value of $36.9 billion. From an investment attractiveness vantage point, MTP is ranked squarely in the bottom quartile of the sector with a ranking of 638 among the 782 companies in the sector; the stock's Portfolio Grader ranking currently places it 279 among the 350 companies in this industry group, a position that is well below-average and number 3,833 in the 5000 company Portfolio Grader company universe.

Regeneron Pharmaceuticals (REGN) a Hold on Vapid Quant Score

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is classified as a component of the 350 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. REGN's market value is $40.1 billion which places it in the top decile in its industry group. The current Portfolio Grader ranking for REGN puts it 188 among the 350 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 428 among the 782 companies in the sector, and number 2,601 in the nearly 5,000 company Portfolio Grader universe.

Lousy Quant Score Make Shire (SHPG) a Sell

Shire plc (NASDAQ:SHPG) is a constituent of the 350 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. SHPG's market value is $44.8 billion which places it in the top 10% of its industry group. The current Portfolio Grader ranking for SHPG puts it 233 among the 350 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 538 among the 782 companies in the sector, and number 3,229 in the nearly 5,000 company Portfolio Grader universe.

It’s Not Too Late to Profit on the Buffalo Wild Wings Stock Buyout

A private equity firm is considering a buyout of Buffalo Wild Wings, but a  rival group is interested too. What does this mean for BWLD stock?

Robust Quant Score Make Cellect Biotechnology (APOP) a Buy

Cellect Biotechnology Ltd (NULL:APOP) is ranked as a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Biogen (BIIB) a Hold on Uninspiring Sales Growth

Portfolio Grader currently ranks Biogen Inc (NASDAQ:BIIB) a Hold. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. BIIB has maintained this ranking for 3 months.

Lowes (LOW) a Buy on Strong Quant Score

Currently, Lowes Companies (NYSE:LOW) has a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. LOW has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Poor Earnings Growth Drop Time Warner (TWX) to Sell

Currently, Time Warner Inc (NYSE:TWX) has a Sell using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. The shares have been downgraded from a Hold to a Sell in the last week.

Sinking Industry Group Rank Keep Celgene (CELG) a Sell

With a $80.4 billion market value, Celgene Corp (NASDAQ:CELG) ranks in the top decile in its industry group, Biotechnology, and in the top decile of sector group, Health Care, in market value. From the vantage point of investment attractiveness, The current Portfolio Grader ranking for CELG puts it 218 among the 350 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 499 among the 782 companies in the sector, and number 3,010 in the nearly 5,000 company Portfolio Grader universe.